Clinical Trials Browser

Phase 1 × INDUSTRY × aumolertinib × Clear all

NCT05430386 2023-02-14

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05223595 2022-02-04

A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung